CTOS 2016

Trabectedin or Gemcitabine-Taxotere in Relapsed Uterine Leiomyosarcoma (U-LMS)

Phase 2 Study of Regorafenib in Patients with Metastatic STS (RESOUND)

Adjuvant Therapies in Major Histological Subtypes of Extremity Soft-Tissue Sarcoma (STS)

Alternate Dosing Regimen of Regorafenib in Gastrointestinal Stromal Tumors (GISTs)

Outcomes of Older Patients with Osteosarcoma from the French Group Sarcoma (GSF-GETO)

Trabectedin Approved for Use in Uterine Leiomyosarcoma

In this interview, Martee Hensley, MD, a medical oncologist practicing at Memorial Sloan Kettering Cancer Center, commented on the introduction of trabectedin as a treatment alternative for women with uterine leiomyosarcoma. Read More ›

Page 2 of 2

1
2